Increased serum HMGB1 is related to oxidative stress in patients with atrial fibrillation

Journal of International Medical Research

Volumn 41, Issue 6, 2013, Pages 1796-1802

  Wu, Yongbo ^a,b   Zhang, Kai ^a,b   Zhao, Lin ^a,b   Guo, Jie ^a,b   Hu, Xiaorong ^a,c,d   Chen, Zhiqiang ^a,b  

^a HUBEI POLYTECHNIC UNIVERSITY   (China)

^b Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention   (China)

^c RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^d WUHAN UNIVERSITY   (China)

Author keywords

atrial fibrillation; High mobility group box 1 protein; inflammation; oxidative stress

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HIGH MOBILITY GROUP B1 PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; ORAL ANTIDIABETIC AGENT; PROPAFENONE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GROUPS BY AGE; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM DIAMETER; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PAROXYSMAL HEART ATRIUM FIBRILLATION; PERSISTENT HEART ATRIUM FIBRILLATION; POSTPRANDIAL STATE; SMOKING; SYSTOLIC BLOOD PRESSURE;

ATRIAL FIBRILLATION; HIGH MOBILITY GROUP BOX 1 PROTEIN; INFLAMMATION; OXIDATIVE STRESS;

AGED; ATRIAL FIBRILLATION; FEMALE; HMGB1 PROTEIN; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 84888269508     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513503917     Document Type: Article

References (20)

1. Kannel WB,Abbott RD,Savage DD, et al.Epidemiologic features of chronic atrial fibrillation: the Framingham study.N Engl J Med. 1982;306:1018-1022.
2. Go AS,Hylek EM,Phillips KA, et al.Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.JAMA. 2001;285:2370-2375.
3. Watanabe E,Arakawa T,Uchiyama T, et al.High-sensitivityC-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion.Int J Cardiol. 2006;108:346-353.
4. Issac TT,Dokainish H,Lakkis NM.Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data.J Am CollCardiol. 2007;50:2021-2028.
5. Tousoulis D,Zisimos K,Antoniades C, et al.Oxidative stress and inflammatory process in patients with atrial fibrillation: the role of left atrium distension.Int J Cardiol. 2009;136:258-262.
6. Bell CW,Jiang W,Reich CF, et al.The extracellular release of HMGB1 during apoptotic cell death.Am J Physiol Cell Physiol. 2006;291:C1318-C1325.
7. Hu X,Jiang H,Bai Q, et al.Increased serum HMGB1 is related to the severity of coronary artery stenosis.Clin Chim Acta. 2009;406:139-142.
8. Hu X,Zhou X,He B, et al.Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats.Eur J Pharmacol. 2010;638:84-89.
9. Giallauria F,Cirillo P,Lucci R, et al.Autonomic dysfunction is associated with high mobility group box-1 levels in patients after acute myocardial infarction.Atherosclerosis. 2010;208:280-284.
10. Wang H,Bloom O,Zhang M, et al.HMG-1 as a late mediator of endotoxin lethality in mice.Science. 1999;285:248-251.
11. Salman S,Bajwa A,Gajic O, et al.Paroxysmal atrial fibrillation in critically ill patients with sepsis.J Intensive Care Med. 2008;23:178-183.
12. Hu X,Zhou W,Bai Q, et al.Increased serum high mobility group box 1 protein in patients with atrial fibrillation.Biomed Aging Pathol. 2011;1:52-55.
13. Hu XR,Wang XH,Liu HF, et al.High mobility group box 1 protein: possible pathogenic link to atrial fibrillation.Chin Med J (Engl). 2012;125:2346-2348.
14. Fuster V,Rydén LE,Cannom DS, et al.ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.Circulation. 2006;114:e257-e354.
15. Zhao D,Wang Y,Xu Y.Decreased serum endogenous secretory receptor for advanced glycation end products and increased cleaved receptor for advanced glycation end products levels in patients with atrial fibrillation.Int J Cardiol. 2012;158:471-472.
16. Yamada S,Maruyama I.HMGB1, a novel inflammatory cytokine.Clin Chim Acta. 2007;375:36-42.
17. Andersson U,Wang H,Palmblad K, et al.High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.J Exp Med. 2000;192:565-570.
18. Korantzopoulos P,Kolettis TM,Galaris D, et al.The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation.Int J Cardiol. 2007;115:135-143.
19. Van Wagoner DR.Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target.J Cardiovasc Pharmacol. 2008;52:306-313.
20. Tang D,Shi Y,Kang R, et al.Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1.J Leukoc Biol. 2007;81:741-747.